Back to search

Article

Target Amplicon Deep Sequencing of Pfk13 gene in patients with Plasmodium falciparum malaria during the therapeutic efficacy study trials from 2020 to 2022 in Senegal

2026-05-04

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Artemisinin-based combination therapies (ACTs) remain the cornerstone of malaria treatment in Africa. However, the emergence of <italic>Plasmodium falciparum</italic> artemisinin partial resistance associated with mutations in the <italic>pfk13</italic> gene in Southeast Asia and East Africa raises concern about its potential emergence or spread to West A...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd7ef92c-f69c-5c18-9536-ec46a53fd0d7
DOI
10.21203/rs.3.rs-9272508/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Target Amplicon Deep Sequencing of Pfk13 gene in patients with Plasmodium falciparum malaria during the therapeutic efficacy study trials from 2020 to 2022 in SenegalDOI 10.21203/rs.3.rs-9272508/v1
Emerging threat of Partial Artemisinin Resistance Markers in P. falciparum Parasite Populations in multiple geographical locations in high Transmission Regions of UgandaSemantic proximity
Emergence and Spread of Plasmodium falciparum Kelch 13 Mutations in Selected Counties of Kenya: Implications for Responding to Artemisinin Partial Resistance.Semantic proximity
Longitudinal surveillance of kelch13 identifies C469Y, P553L, R561H and A675V mutations associated with artemisinin resistance in Western KenyaSemantic proximity
Sentinel surveillance of the WHO-validated Pfkelch13 C580Y artemisinin resistance marker in Plasmodium falciparum isolates from Bangui, Central African RepublicSemantic proximity
Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda.Semantic proximity
Spatial Surveillance of Plasmodium falciparum Kelch 13 Mutations Reveals Emerging Artemisinin Resistance in KenyaSemantic proximity
Drug resistance gene polymorphisms of Plasmodium falciparum Kinshasa clinical isolatesSemantic proximity
Understanding the Global Spread of Artemisinin Resistance: Insights from over 100K <i>Plasmodium falciparum</i> SamplesSemantic proximity
Prevalence of PfKelch13 Mutations and Clinical Indicators of Artemisinin Partial Resistance in Africa: A Systematic Review and Meta-Analysis of Observational CohortsSemantic proximity
The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis.Semantic proximity
Genetic Architecture and Dynamics&nbsp;of PfKelch13’s Propeller Domain in Plasmodium Falciparum Clinical Isolates Collected in Senegal.Semantic proximity
Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing.Semantic proximity
Select a neighboring publication to make it the new centre.